ASX - Delayed Quote AUD

Sigma Healthcare Limited (SIG.AX)

3.0400
-0.0200
(-0.65%)
As of 1:55:17 PM GMT+10. Market Open.
Currency in AUD All numbers in thousands
Download
Breakdown
TTM
1/31/2025
1/31/2024
1/31/2023
1/31/2022
Total Revenue
4,893,936
4,893,936
3,375,766
3,660,240
3,515,563
Cost of Revenue
4,559,883
4,559,883
3,103,916
3,405,832
3,219,056
Gross Profit
334,053
334,053
271,850
254,408
296,507
Operating Expense
344,134
344,134
290,090
329,816
337,290
Operating Income
-10,081
-10,081
-18,240
-75,408
-40,783
Net Non Operating Interest Income Expense
-10,511
-10,511
-14,579
-13,810
-10,620
Other Income Expense
31,738
31,738
41,443
94,680
43,096
Pretax Income
11,146
11,146
8,624
5,462
-8,307
Tax Provision
24,064
24,064
3,313
2,435
-1,971
Net Income Common Stockholders
-13,842
-13,842
4,509
1,811
-7,239
Basic EPS
-0.00
-0.01
0.00
0.00
-0.01
Diluted EPS
-0.00
-0.01
0.00
0.00
-0.01
Basic Average Shares
1,297,756.9020
1,571,640
1,024,448
1,020,825.9810
1,018,764.5230
Diluted Average Shares
1,297,756.9020
1,571,640
1,024,448
1,020,825.9810
1,018,764.5230
Net Income from Continuing & Discontinued Operation
-13,842
-13,842
4,509
1,811
-7,239
Normalized Income
-13,842
-13,842
4,509
6,703.3000
-5,982.7833
Interest Income
8,003
8,003
1,724
597
221
Interest Expense
18,514
18,514
16,303
14,407
10,841
Net Interest Income
-10,511
-10,511
-14,579
-13,810
-10,620
EBIT
29,660
29,660
24,927
19,869
2,534
EBITDA
55,472
55,472
53,250
50,205
30,225
Reconciled Cost of Revenue
4,559,883
4,559,883
3,103,916
3,405,832
3,219,056
Reconciled Depreciation
25,812
25,812
28,323
30,336
27,691
Net Income from Continuing Operation Net Minority Interest
-13,842
-13,842
4,509
1,811
-7,239
Total Unusual Items Excluding Goodwill
--
--
--
-6,989
-1,647
Total Unusual Items
--
--
--
-6,989
-1,647
Normalized EBITDA
55,472
55,472
53,250
57,194
31,872
Tax Rate for Calcs
0.0004
0.0004
0.0004
0.0003
0.0002
Tax Effect of Unusual Items
0
0
0
-2,096.7000
-390.7833
1/31/2022 - 1/3/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

EBO.NZ EBOS Group Limited
38.75
-0.39%
 
AMPm.XC
 
EBOSY EBOS Group Limited
41.94
0.00%
 
AMFPF Amplifon S.p.A.
22.02
0.00%
 
NVLG.TA Novolog (Pharm-Up 1966) Ltd
152.60
-1.93%
 
ARJO-B.ST Arjo AB (publ)
31.50
+1.35%
 
GALE.SW Galenica AG
85.00
-2.35%
 
AMP.VI Amplifon S.p.A.
19.25
+2.86%
 
QIPT.TO Quipt Home Medical Corp.
2.9800
-1.32%
 
EDAP EDAP TMS S.A.
2.1500
-2.93%